S, A., S, M., K, B., M, L., Y, M., J, L., . . . G, Z. (2019). Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 25(2), 844. https://doi.org/10.1158/1078-0432.CCR-18-1854
Chicago Style (17th ed.) CitationS, Agnihotri, et al. "Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25, no. 2 (2019): 844. https://doi.org/10.1158/1078-0432.CCR-18-1854.
MLA (9th ed.) CitationS, Agnihotri, et al. "Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 25, no. 2, 2019, p. 844, https://doi.org/10.1158/1078-0432.CCR-18-1854.